ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

ACUTA CAPITAL PARTNERS, LLC's Holding History (CIK: 0001582844)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025

Shares 265,269 Value ($000) $5,220 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 267,368 Value ($000) $6,016 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 296,368 Value ($000) $7,569 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 397,698 Value ($000) $9,294 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 396,099 Value ($000) $6,967 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 123,876 Value ($000) $1,714 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 103,600 Value ($000) $1,415 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 104,500 Value ($000) $2,133 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 30,979 Value ($000) $678 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2025	265,269	$5,220	$21.52	$18.67 - $25.37
Q4 2024	267,368	$6,016	$25.92	$21.43 - $30.03
Q3 2024	296,368	$7,569	$23.16	$20.63 - $27.67
Q2 2024	397,698	$9,294	$21.05	$15.96 - $26.00
Q1 2024	396,099	$6,967	$15.34	$10.90 - $19.50
Q4 2023	123,876	$1,714	$12.23	$9.80 - $15.41
Q3 2023	103,600	$1,415	$16.84	$12.38 - $20.77
Q2 2023	104,500	$2,133	$20.21	$17.15 - $23.98
Q1 2023	30,979	$678	$20.34	$14.56 - $25.34